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ABSTRACT. A 2.5-year-old male German shepherd-cross dog was admitted for progressively deteriorating regurgitations of 
one-month duration. Physical examination was unremarkable, apart from a poor body condition; also, neurological examination 
did not reveal any abnormality. In thoracic survey radiographs, a generalized esophageal dilation, consistent with megaesophagus, 
was well visualized. An increased nicotinic acetylcholine receptor antibody titer confirmed the diagnosis of acquired focal 
myasthenia gravis expressed as megaesophagus in this patient. The only help offered to the dog was a modification of its feeding 
habits (upright position, small and frequent meals). Within two months of the initial admission and prior to institution of specific 
treatment for myasthenia gravis, the dog experienced spontaneous and complete clinical remission and remained healthy for the 
next two years, eating again the normal way, but unfortunately was lost to follow-up. The favourable outcome of megaesophagus 
due to localized myasthenia gravis is discussed accordingly. 
Keywords: acquired megaesophagus, localized myasthenia gravis, dog 
ΠΕΡΙΑΗΨΗ. Γερμανικός Ποιμενικός σκύλος που ήταν αρσενικός και είχε ηλικία 2,5 χρονών προσκομίστηκε επειδή κατά 
τον τελευταίο μήνα παρουσίασε ανάγωγες που επιδεινώνονταν προοδευτικά. Στην κλινική και τη νευρολογική εξέταση δεν 
παρατηρήθηκε κάτι το αξιόλογο, εκτός από την κακή θρεπτική κατάσταση του ζώου. Στα ακτινογραφήματα του τραχήλου και 
του θώρακα παρατηρήθηκε σαφής διάταση του οισοφάγου καθ'όλο το μήκος του, που οδήγησε στη διάγνωση του μεγαοισοφάγου. 
Στην εργαστηριακή διερεύνηση διαπιστώθηκε ότι ο τίτλος αντισωμάτων κατά των υποδοχέων της ακετυλοχολίνης στον ορό 
του αίματος ήταν αυξημένος, γεγονός που θεμελίωσε τη διάγνωση του επίκτητου μεγαοισοφάγου από εντοπισμένη βαριά 
μυασθένεια. Η μόνη βοήθεια που προσφέρθηκε στο ζώο, με σκοπό τη βελτίωση της θρεπτικής του κατάστασης και την αποφυγή 
της εισροφητικής βρογχοπνευμονίας, ήταν η αλλαγή του τρόπου παράθεσης της τροφής (τάισμα σε όρθια στάση, μικρά 
γεύματα). Ο σκύλος, μέσα σε δύο μήνες από την προσκόμιση του και πριν από τη χορήγηση οποιασδήποτε θεραπευτικής 
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αγωγής κατά της μυασθένειας, παρουσίασε πλήρη κλινική ύφεση, που διατηρήθηκε για τουλάχιστον δυο χρόνια μετά τη 
διάγνωση της πάθησης. Δυστυχώς, έκτοτε δεν μπορέσαμε να έλθουμε σε επαφή με τον ιδιοκτήτη του ζώου. Η κλινική εικόνα, 
η διαγνωστική προσέγγιση, η θεραπευτική αντιμετώπιση και η ευνοϊκή εξέλιξη συζητούνται στο τέλος της εργασίας αυτής. 
Λέξεις ευρετηρίασης: επίκτητος μεγαοισοφάγος, εντοπισμένη βαριά μυασθενεια, σκύλος 
CASE HISTORY 
A2.5 years old male German Shepherd-cross dog was referred with a history of progressively 
increasing regurgitations of one month duration. 
Physical examination, including a thorough neurologic 
evaluation, was unremarkable, except for the poor 
body condition score (2/5). Regurgitations were, also, 
noticed within an hour after having eaten solid food in 
the Clinic. Complete blood count (CBC), serum 
biochemistry and urinalysis revealed no abnormalities. 
The dog was tested negative for Leishmania infantum 
and Ehrlichia canis antibodies and Dirofilaria immitis 
antigens. Fecal analysis, performed by employing the 
Teleman sedimentation technique, was negative for 
Spirocerca lupi eggs. Cervical and thoracic plain 
radiographs demonstrated an extensive and severe 
dilation of esophagus, the lumen of which was filled 
with gas. Further evidence of megaesophagus was the 
ventral displacement of trachea, sharp interface 
between longus colli muscles and esophageal lumen 
and paired converging soft tissue stripes at the 
dorsocaudal aspect of the thorax (Figure 1). In an 
attempt to investigate the underlying causes of 
megaesophagus, the adrenocorticotropic hormone 
(ACTH) stimulation test and acetylcholine receptor 
(AChR) antibody titer by radioimmunoassay 
immunoprecipitation (Cambridge specialist laboratory 
services, Cambridge, UK) were performed. ACTH test 
was unremarkable, but AChR antibody titer was proved 
to be increased (1.46 nmol/L, reference range: <0.6 
nmol/L), leading to suspicion of megaesophagus 
secondary to acquired myasthenia gravis (MG). Pending 
the result of AChR antibody titer, the dog was fed with 
a semisolid home made diet, offered in small meals and 
holding the dog in an upright position for a few minutes 
post-feeding. Oral cisapride (Alimix, Janssen-Cilag, 
Greece) was, also, given at the dose of 0.5 mg/kg B.W., 
every 8 hours, for 3 weeks. After two months, a 
telephone communication with the owner revealed a 
complete cessation of regurgitations without the aid of 
cholinergic medication. The dog has been clinically 
normal for two years since the initial admission. 
DISCUSSION 
Acquired megaesophagus, characterized by wall 
hypomotility and eventually lumen dilation, is perhaps 
the most common esophageal disorder in the dog 
(Tarns 2003). 
When the lumen is gas-filled, the diagnosis is 
straightforward even on survey radiographs, but not 
when it is fluid-filled. The characteristic features of 
megaesophagus in this dog were amply visualized in 
plain lateral radiographs (Wartous 2002), thus not 
justifying the need for contrast radiography. However, 
in most megaesophagus cases involving the adult dog, 
no underlying cause can be found, making the usual 
diagnosis of "idiopathy" unavoidable (Mears and 
Jenkins 1997, Gaynor et al. 1997). On the other hand, 
several central and peripheral neuropathies, 
junctionopathies and myopathies have been associated 
with megaesophagus (Johnson et al. 2009). The 
frequency of MG secondary to "idiopathy" in canine 
acquired megaesophagus is high and, therefore, it 
should be one of the top differentials (Tarns 2003, 
Washabau 2005). So far, the generalized and focal 
forms of acquired MG have been recognized. Lack of 
historical or clinical evidence of episodic weakness, 
supported by the age and the breed of this dog, were 
suggestive of the localized form of the disease (Shelton 
et al. 1997, Otte et al. 2003). Many dogs initially 
diagnosed with "idiopathic" megaesophagus may 
actually have focal MG, as it has been the case with our 
dog, although a complete laboratory investigation was 
not possible to pursue. Shelton et al. (1990) tested 
serum samples obtained from 152 dogs with 
"idiopathic" megaesophagus for AChR antibodies, 
only to find that 40 of them (26%) had titers diagnostic 
for MG, as we witnessed in this dog. This test is 
considered to be the "gold standard" in the diagnosis 
of canine MG (Shelton 2002). At least 2% of dogs with 
generalized MG have been tested negative for AChR 
antibody, but the corresponding figures for localized 
MG are still not available (Shelton 1998). Despite the 
dramatic improvement of muscle strength noticed in 
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Figure 1. 
Lateral view of the thorax 
demonstrating dilation of the 
entire esophagus with a gas 
filled lumen. The hallmark 
signs of the generalized 
esophageal dilation, 
including the tracheal stripe 
sign (a), the sharp interface 
between the longus colli 
muscles and the esophageal 
lumen (b) and the paired 
converging soft tissue stripes 
at the dorsocaudal aspect of 
the thorax (c), are seen. 
dogs with the generalized type of MG undergoing the 
Tensilon test (edrophonium chloride), esophageal 
musculature is not responding well, thus limiting the 
diagnostic value in the localized MG (Shelton 2002, 
Inzana 2006). Since there is a possibility MG to appear 
secondarily to some autoimmune or neoplastic 
disorders (e.g. thymoma), a diagnostic search to this 
direction is advisable (Shelton 2002). However, CBC, 
serum biochemistry and urinalysis did not reveal any 
abnormality in this dog and thoracic radiography ruled 
out the existence of cranial mediastinal masses. 
Although hypoadrenocorticism is an uncommon 
cause of megaesophagus in the dog, some cases, not 
accompanied by serum electrolyte abnormalities, have 
been presented with regurgitation as the main 
complaint; also, the potential of self-cure justifies the 
ACTH stimulation test in every dog with acquired 
megaesophagus (Bartges and Nielson 1992, Johnson 
et al. 2009). Nevertheless, no clinical and/or 
clinicopathological evidence of hypoadrenocorticism 
was witnessed in this dog. Hypothyroidism has, also, 
been included in the etiology of canine megaesophagus 
(Dewey 2003), though the thyroid profile was not 
evaluated in this dog due to financial restrictions. On 
the other hand, in a large-scale retrospective case-
control study dealing with the risk factors that may lead 
to acquired megaesophagus in the dog, hypothyroidism 
was not incriminated even in a single case (Gaynor et 
al. 1997). 
Canine spirocercosis is a relatively common cause 
of esophageal dysphagia and regurgitations, especially 
among hunting breed dogs living in Greece (Mylonakis 
et al. 2006). Our dog was negative for S. lupi eggs after 
having employed the fecal sedimentation technique. 
On thoracic radiographs, the characteristic finding of 
canine spirocercosis is an accumulation of intraluminal 
air and not the diffuse esophageal dilation that is 
typically seen in megaesophagus cases (Dvir et al. 2001, 
Mylonakis et al. 2006). 
Similar to our case, as high as 88.7% of the dogs with 
either localized or generalized MG have been into 
spontaneous serologic and clinical remission on an average 
of 6.4 months after diagnosis (range: 1-18 months) 
(Shelton 2002). Unfortunately, the measurement of 
AChR antibody titer and thoracic radiography were not 
repeated to see if any improvement occurred. Despite 
the relapses witnessed occasionally (Tarns 2003), our 
dog has been clinically normal for at least the last two 
years since the admission. Some affected dogs may 
progress to generalized MG, although this usually 
happens during the first weeks after the appearance of 
regurgitations (Tarns 2003). 
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In dogs with megaesophagus, food is fed in small 
meals given several times daily, with the dog held in an 
upright position; this kind of feeding provides 
adequate control of regurgitation in many animals 
(Johnson et al. 2009). Food trials are the best way to 
determine which type of food is more helpful in the 
particular dog (Johnson et al. 2009). The therapeutic 
value of cisapride has been questioned, since it is 
known to increase the motility of smooth, but not of 
striated muscles that predominate in the canine 
esophagus. Moreover, in normal dogs, cisapride 
actually decreases esophageal transit time of food 
bolus (Mears and Jenkins 1997), thus making it 
difficult to evaluate its effectiveness in this dog. 
Localized MG is traditionally treated with long-acting 
anticholinesterase medications, such as pyridostigmine 
bromide and neostigmine, but this did not apply in our 
case because of the spontaneous recovery that was 
witnessed (Johnson et al. 2009). 
In conclusion, dogs admitted with acquired 
megaesophagus should be investigated for underlying 
diseases, before being tagged "idiopathic". Poor 
prognosis associated with the latter disease and the 
potential of permanent cure following the treatment 
of the underlying diseases makes the pursuit of 
extensive laboratory evaluation fully advisable. • 
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